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Abstract⎯The effect of an alternating magnetic field with a magnetic f lux density of 150 mT on the blood
oxygen-transport function was studied. In vitro exposure of blood cells was performed following a 10-day
series of in vivo exposure of the rat tail artery in combination with administration of chemical compounds that
affect the formation of gaseous transmitters. In vitro exposure to a magnetic field changed the oxygen-trans-
port function of the blood, as observed by a greater decrease in the affinity of hemoglobin for oxygen and an
increase in the concentration of gaseous transmitters (nitric oxide  and hydrogen sulfide). In animals to which
nitroglycerin and sodium hydrosulfide were administered exposure to a magnetic field caused a shift in the
oxyhemoglobin dissociation curve to the right; this effect was absent when a nonselective inhibitor of the NO
synthase enzyme or an irreversible inhibitor of the cystathionine γ-lyase enzyme was added. These results sug-
gest that the magnetic field affects the oxygen-binding properties of the blood by modifying intra-erythrocyte
mechanisms that involve gaseous transmitters.
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Among the numerous abiotic environmental fac-
tors that can induce significant changes in the func-
tional condition of biological systems of different
complexities, electromagnetic waves are of particular
importance [1]. Application of a magnetic field (MF)
is a leading physiotherapeutic technique used for cor-
rection of different pathological conditions, in combi-
nation with or sometimes even without drug-based
treatment [2]. It was shown that exposure to an MF
has a pronounced physiological effect, inducing a
wide range of adaptive responses in the body [3]. The
tissues with the highest sensitivity to an MF are the
blood and the cardiovascular, endocrine, and muscu-
loskeletal systems, as well as the CNS [4].
The oxygen-transport function of the blood
enables long- and short-term adaptation to hypoxia
[5]. The modulation of the affinity of hemoglobin to
oxygen is of central importance for the oxygen-bind-
ing capacity of the blood and allows adaptation to the
constantly varying demand for oxygen [6]. An import-
ant role belongs to intracellular factors, such as 2,3-
diphosphoglycerate or pH levels [7]. On the whole, the
oxygen-binding characteristics are modulated by dif-
ferent allosteric effectors that enable adaptation to
hypoxia [8]. The affinity of hemoglobin to oxygen is
largely determined by hemoprotein and various physi-
ological modulating agents, which constitute the
intra-erythrocyte regulatory system [9].
Among the signaling molecules involved in the
inter- and intracellular regulatory networks in differ-
ent tissues, a special role belongs to gasotransmitters:
gaseous compounds involved in the functioning of dif-
ferent human organs and systems under normal and
pathological conditions [10, 11]. In our previous
works, we investigated the role of nitric oxide (NO)
and hydrogen sulfide in mediating the effect of an MF
on the oxygen-transport function of blood. Experi-
ments performed both in vivo [12], and in vitro [13]
have shown that exposure to an MF caused a right-
wards shift of the oxyhemoglobin dissociation curve
(ODC); in the latter case it was mediated by intracel-
lular mechanisms involving, in particular, hydrogen
sulfide and NO gasotransmitters. It is important to
investigate MF-induced changes of oxygen-binding
properties of blood in an experiment where in vivo
exposure to an MF is combined with subsequent expo-
sure of blood specimens in vitro. Based on the previ-
ously obtained data, we have undertaken a study of the
adaptive response of blood cells under the same con-
ditions.
It should be noted that many aspects of MF-
induced changes in blood properties, in particular, the
role of intracellular modulating agents, are insuffi-
Abbreviations used: MF, magnetic field; L-NAME, N(G)-nitro-
L-arginine methyl ester; ODC, oxyhemoglobin dissociation
curve; PAG, DL-propargyl glycine; nitric oxide (NO).436
THE IN VITRO EFFECT OF A MAGNETIC FIELD 437ciently understood. Therefore, the goal of the present
work was to investigate the effect of an MF on the oxy-
gen-transport function and the gasotransmitter system
in rat blood in vitro, following a 10-day series of tail
artery exposure to the same factor in the presence of
chemical agents that modulate the formation of gas-
otransmitters.
MATERIALS AND METHODS
Experiments were performed on male white rats
with a body weight of 250–280 g, n = 90. Animals were
kept in the same vivarium conditions with a standard
feeding regimen and unlimited water supply. The
study design was approved by the Biomedical Ethics
Committee.
The rats were divided into nine groups: intact
(group 1), control (group 2), and experimental
(groups 3–9) rats, which were exposed to an MF and
administered compounds that modulate the produc-
tion of gaseous transmitters: NO and hydrogen sul-
fide. The tail artery of the experimental rats was
exposed to an MF for 10 min daily during 10 days. A
HemoSpok device (MagmoMed, Belarus) served as
the MF source. Current impulses with a frequency of
60 to 200 Hz with 10 Hz frequency modulation were
applied to the inductor to generate a magnetic f lux
density of 150 mT. Blood specimens taken from ani-
mals of groups 3–9 were re-exposed to an MF in vitro
for 120 s under the same conditions.
To modulate the formation of gasotransmitters, the
rats were administered intraperitoneal infusions of the
following compounds: 1.5 mg/kg nitroglycerin
(SchwarzPharma AG, Germany) as a donor of free
NO (group 4); nitroglycerin together with 10 mg/kg
N(G)-nitro-L-arginine methyl ester (L-NAME;
Sigma Aldrich, United States), an NO synthase inhib-
itor (group 5); nitroglycerin together with 10 mg/kg
DL-propargylglycine (PAG, Chem-Impeх Interna-
tional, United States), an irreversible cystathionine-γ-
lyase inhibitor (group 6); 5 mg/kg NaHS (Sigma-
Aldrich), a hydrogen sulfide donor (group 7); NaHS
and PAG (group 8); and NaHS and L-NAME
(group 9). Rats of group 3 received physiological
saline. The chemicals were injected daily at a volume
of 1 mL for 10 days.
Under adequate sodium thiopental anesthesia
(50 mg/kg), 6 mL of mixed venous blood was col-
lected from the right atrium in a syringe containing
50 units heparin per 1 mL blood.
The parameters of the oxygen-transporting func-
tion: pO2, pCO2, and oxygen saturation (SO2), as well
as acid–base equilibrium parameters: the standard
bicarbonate concentration (SBC), the ratio between
the actual and standard base excess (ABE/SBE), the
hydrocarbonate concentration ( ), the hydrogen
ion concentration (pH), and total plasma carbon diox-
ide (TCO2), were determined at 37°C on a Stat Profile
3HCO
−BIOPHYSICS  Vol. 63  No. 3  2018pHOx Plus L analyzer (United States). Hemoglobin
affinity to oxygen was assessed spectrophotometrically
by the p50 value (pO2 at 50% blood saturation with
oxygen); p50stand was calculated using the Severing-
haus formulas. Based on these data, the Hill equation
was used to determine the position of the oxyhemo-
globin dissociation curve (ODC).
NO production was assessed according to the ratio
between the nitrate and nitrite ion levels in plasma
( / ) using the Griess reagent test evaluated at
540 nm on a PV1251C spectrophotometer (SOLAR,
Belarus) [14]. Hydrogen sulfide levels were deter-
mined by spectrophotometric evaluation of the reac-
tion between sulfide anions and acidic solution of
N,N-dimethyl-p-phenylenediamine hydrochloride in
the presence of ferric chloride at 670 nm [15].
The data were analyzed by ANOVA using Statisticа
10.0 software. The Shapiro–Wilks test was applied to
evaluate the normality of the distribution for each
dataset. The significance of the variance analysis for
multiple comparisons was assessed using the Mann–
Whitney test. The significance threshold was P < 0.05.
RESULTS AND DISCUSSION
The data describing the effect of in vitro exposure
to an MF on the oxygen-transport function of the
blood are summarized in Table 1. It can be seen that
the parameters of the acid–base equilibrium in the
blood did not change significantly either in rats
exposed to an MF in vivo or in experiments with sub-
sequent blood re-exposure in vitro.
The affinity of hemoglobin to oxygen changed,
since p50act and p50stand increased, indicating a right-
wards shift of the ODC (Fig. 1). There was also an
increase in the oxygen saturation and pO2 values. The
total /  content in plasma increased to 9.5 ±
0.39 μmol/L (P < 0.05 in comparison to intact rats).
The hydrogen sulfide concentrations increased from
12.19 ± 0.32 to 14.73 ± 0.39 μmol/L (P < 0.05).
In the experiment where a 10-day series of expo-
sure to an MF in vivo was followed by in vitro exposure
of blood specimens, p50act and p50stand increased more
significantly than the values observed in group 2
(exposed to an MF only in vivo), indicating a further
rightwards shift of the ODC, similarly to in vivo exper-
iments (Fig. 1). The content of /  and H2S
also increased significantly, reaching 14.03 ± 0.60 (P <
0.05) and 18.47 ± 0.88 μmol/L (P < 0.05), respec-
tively.
Taking the fact into account that exposure to an
MF activates the production of NO and H2S, as sug-
gested by the increase in /  and hydrogen sul-
fide concentrations in the plasma, and that the mech-
anisms mediating the effects of these gasotransmitters
are mutually coupled, we performed a series of exper-
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Fig. 1. The effect of exposure to a magnetic field on the
oxyhemoglobin dissociation curve. Filled squares, control;
open squares, MF; triangles, MF (in vitro).
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SO2, %iments using chemical agents that influence the for-
mation of these signaling molecules.
In these experiments, exposure to an MF in vitro
was also performed after a 10-day series of exposure in
vivo; the results were as follows. In group 4 that
received nitroglycerin, p50act was higher than in
group 2, but did not differ significantly from the values
of group 3. A similar result was observed for p50stand.
The levels of oxygen saturation and oxygen pressure in
the blood also increased. The plasma concentrations
of /  and hydrogen sulfide were elevated to
18.09 ± 0.26 (P < 0.05) and 22.97 ± 0.62 μmol/L (P <
0.05), respectively.
When nitroglycerin was administered in combina-
tion with L-NAME (group 5), p50act and p50stand were
lower and did not differ from the control values, in
spite of exposure to an MF, which indicated that the
MF did not affect affinity of hemoglobin to oxygen.
There was also a decrease in SO2 and pO2 values, as
well in the concentrations of /  (to 8.73 ±
0.58 μmol/L, P < 0.05) and hydrogen sulfide (to
8.06 ± 0.17 μmol/L, P < 0.05). A similar dynamics of
these parameters was observed in group 6, where
nitroglycerin was administered together with PAG.
In group 7 that was administered NaHS as hydro-
gen sulfide donor, exposure to an MF resulted in an
increase in p50act and p50stand, as well as in SO2 and
pO2 values. At the same time, the concentrations of
gasotransmitters increased to 15.96 ± 0.42 μmol/L for
/  (P < 0.05) and to 26.03 ± 0.52 μmol/L for
H2S (P < 0.05). In animals of group 8, which
received NaHS together with PAG, the values of
2NO
−
3NO
−
2NO
−
3NO
−
2NO
−
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−BIOPHYSICS  Vol. 63  No. 3  2018p50act, p50stand, SO2, and pO2 were lower and did not
differ from those of intact rats. Administration of the
cystathionine-γ-lyase inhibitor also suppressed gas-
otransmitter production: the concentrations of
/  and hydrogen sulfide decreased to 9.19 ±
0.27 μmol/L (P < 0.05) and 9.55 ± 0.67 μmol/L (P <
0.05), respectively. Similar results were obtained in
group 9 (MF + NaHS + L-NAME).
Previously, we showed that exposure to an MF in
vitro diminished affinity of hemoglobin to oxygen,
which was mediated by activation of the L-arginine–
NO system [13]. Under in vivo conditions, changes in
the oxygen-binding properties of the blood resulting
from exposure to an MF in the presence of L-arginine
or nitroglycerin were observed as one-way decrease in
affinity of hemoglobin to oxygen; no such
changes were present when NO synthase was inhibited
by L-NAME, which suggests that NO participates in
mediating the effect of an MF on the oxygen transport
in the blood [12]. Subsequent experiments concerning
the effect of an MF on the oxygen transport by the
blood showed that oxygen-dependent processes are
modulated not only by NO, but also by hydrogen sul-
fide [16].
A magnetic field can affect a range of blood char-
acteristics. Although the beneficial effect of a single-
time exposure to an MF on the rheological properties
of blood is maintained for no longer than 10–15 min,
long-term MF application (for 10–15 days) was shown
to have a more pronounced and stable effect [17],
since the MF influenced the properties of erythrocytes
both directly and indirectly, by altering their metabo-
lism [18].
The intra-erythrocyte systems that regulates the
properties of hemoglobin was shown to depend on the
metabolic processes within erythrocytes, which
implies the possibility of relatively rapid changes in the
oxygen-binding characteristics of the blood in
response to environmental stimuli [19]. Due to this
mechanism, the position of the ODC can vary consid-
erably depending on the demand for oxygen. The
involvement of NO in the regulation of the oxygen-
binding capacity of hemoglobin on the erythrocyte
level was demonstrated in experiments on blood incu-
bation with nitrosocysteine: the p50act value decreased
by 3.4 ± 0.95 mm Hg (P < 0.05), which caused a left-
wards shift of the ODC [9]. This signaling molecule
acts as an allosteric effector, altering the affinity of
hemoglobin to oxygen and modulating the oxygen-
transport function of the blood [20]. The presence of
NO donors (sodium nitroprusside, S-nitrosoglutathi-
one, or dinitrosyl iron–glutathione complexes) delays
detergent-induced hemolysis and decreases the eryth-
rocyte elasticity modulus, which suggests that NO
donors modulate the structural and functional prop-
erties of erythrocytes [21].
It was shown that hydrogen sulfide stimulates NO
production by inducing the endothelial isoform of NO
2NO
−
3NO
−
440 ZINCHUK, LEPEEVsynthase, but at the same time suppresses the activity
of its inducible isoform, which has a protective effect
on the myocardium in type I diabetes mellitus [22].
The balance between NO production and hydrogen
sulfide in the body determines the level of the vascular
status [23]. Apparently, MF-induced changes in the
affinity of hemoglobin to oxygen are also mediated by
an autonomous intra-erythrocyte system that regu-
lates the oxygen-binding properties of hemoglobin,
where NO and H2S act as important modifiers of its
functional characteristics. Identification of the molec-
ular targets of gasotransmitters, the properties of their
interaction, and the structure of the corresponding
binding sites, as well as understanding the crosstalk
between the NO-, CO-, and H2S-dependent signaling
pathways can be important for the development of
approaches to regulation of these signaling systems in
the case of aberrations [11].
CONCLUSIONS
Our data indicate that in vitro exposure to an MF
following a 10-day series of in vivo exposures modu-
lated the oxygen-transport function of the blood,
which was observed as a more-pronounced decrease
in the affinity of hemoglobin to oxygen. At the same
time, the concentrations of NO and hydrogen sulfide
increased. In animals that received infusions of nitro-
glycerin and sodium hydrosulfide, exposure to an MF
caused a rightwards shift of the ODC and an increase
in the plasma levels of the studied gasotransmitters. In
animals that were administered a nonselective NO
synthase inhibitor (L-NAME) or an irreversible cysta-
thionine γ-lyase inhibitor (PAG), the affinity of
hemoglobin to oxygen did not change, while plasma
concentrations of NO and hydrogen sulfide decreased.
Apparently, the observed changes in the oxygen-bind-
ing characteristics of the blood are mediated by intra-
erythrocyte mechanisms involving gasotransmitters. 
These results may be used in the development of
novel approaches to the correction of disorders involv-
ing oxygen-dependent processes.
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